PCRX

Quote

Short

News

Articles

Message Board

Pacira BioSciences Inc. (NASDAQ : PCRX ) News

Pacira BioSciences Inc. (NASDAQ: PCRX) News Releases

PCRX News Releases

June 04, 2026 04:20:00 pm

PR Newswire

Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual Meeting

June 01, 2026 04:50:00 pm

PR Newswire

Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees

May 28, 2026 04:20:00 pm

GlobeNewswire

Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "FOR" All of Pacira's Director Nominees

May 28, 2026 09:18:00 am

PR Newswire

DOMA PERPETUAL CAPITAL MANAGEMENT QUESTIONS WHY SHAREHOLDERS SHOULD VOTE TO CONTINUE WITH A BOARD THAT HAS OVERSEEN A DECADE OF VALUE DESTRUCTION

May 27, 2026 04:20:00 pm

GlobeNewswire

Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company's Strategic Direction and Highly Qualified Nominees

May 27, 2026 09:00:00 am

GlobeNewswire

After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead

May 27, 2026 08:00:00 am

GlobeNewswire

Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty

May 26, 2026 08:00:00 am

GlobeNewswire

Pacira BioSciences Sets the Record Straight Regarding DOMA's Misleading Statements About Pacira's Intellectual Property Strategy

May 22, 2026 10:09:44 am

GlobeNewswire

A Reno Biotech Just Rang the Nasdaq Bell - Here's Why the Whole Regenerative-Medicine Tape Is Worth Watching

May 21, 2026 02:41:04 pm

SeekingAlpha

Pacira shareholders lobbied by hedge fund board nominees

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account